AiTA Bio Inc. Announces Strategic Additions to Its Board of Directors and Advisory Board
Retrieved on:
Friday, December 8, 2023
Rich Ferrari, an esteemed medical technology executive and venture capitalist, joins AiTA Bio's Board of Directors.
Key Points:
- Rich Ferrari, an esteemed medical technology executive and venture capitalist, joins AiTA Bio's Board of Directors.
- Most recently, Rich served as Chairman and CEO of PQ Bypass, which was acquired by Endologix for $300M+.
- Martin W. Schoeppler, joining AiTA Bio as a Senior Strategic Advisor, brings his transformative vision from his tenure as CEO and President of FUJIFILM Dimatix.
- Jacob Menture and Dilan Casanovas, Founders of AiTA Bio, commented:
"We are thrilled to welcome Rich, Martin, Mark, and David to the AiTA Bio team.